Ex Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems

Table 4

Signal from viable cells (step 2 − step 1).

Samples	Well 1	Well 2	Well 3	Well 4	Well 5	Well 6
10 mg nanoparticles	94	−28	118	192	176	292
10 mg IPB	202	104	148	−70	162	246
Cells only	1814	1278	1796	1328	1348	1850
Fresh medium	−24	42	22	12	16	−24
Empty wells	86	106	84	114	76	62